D’Agostino, Ralph B.

Prediction of coronary heart disease using risk factor categories

Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 9,581

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation

Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

Cited by 7,491

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology

Health Promotion and Cardiovascular PreventionCoronary Interventions and Diagnostics

Cited by 4,945

Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study

Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation

Atrial Fibrillation Management and OutcomesCardiac Health and Mental Health

Cited by 4,575

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Circulation

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 3,697

Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study

Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation

Cardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,882

Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., et al. (2004) · Circulation

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 2,041

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study

Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 1,970

One-year cardiovascular event rates in outpatients with atherothrombosis

Steg, P. G., Bhatt, D. L., Wilson, P. W. F., D’Agostino, R., Ohman, E. M., Röther, J., Liau, C.-S., Hirsch, A. T., Mas, J.-L., Ikeda, Y., et al. (2007) · JAMA

Lipoproteins and Cardiovascular HealthAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,382

Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age

Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., D’Agostino, R. B., Beiser, A., Wilson, P. W. F., Wolf, P. A., & Levy, D. (2006) · Circulation

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 1,298

Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community

Dhingra, R., Sullivan, L., Jacques, P. F., Wang, T. J., Fox, C. S., Meigs, J. B., D’Agostino, R. B., Gaziano, J. M., & Vasan, R. S. (2007) · Circulation

Diet, Metabolism, and DiseaseObesity, Physical Activity, Diet

Cited by 918

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

Bhatt, D. L., Eagle, K. A., Ohman, E. M., Hirsch, A. T., Goto, S., Mahoney, E. M., Wilson, P. W. F., Alberts, M. J., D’Agostino, R., Liau, C.-S., et al. (2010) · JAMA

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 753

Intermittent Claudication: A Risk Profile From The Framingham Heart Study

Murabito, J. M., D’Agostino, R. B., Silbershatz, H., & Wilson, P. W. F. (1997) · Circulation

Peripheral Artery Disease ManagementCardiovascular Health and Risk Factors

Cited by 696

Measures of brain morphology and infarction in the framingham heart study: establishing what is normal

DeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., Beiser, A., D’Agostino, R., & Wolf, P. A. (2005) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

Cited by 680

Effect of Pioglitazone Compared With Glimepiride on Carotid Intima-Media Thickness in Type 2 Diabetes: A Randomized Trial

Mazzone, T., Meyer, P. M., Feinstein, S. B., Davidson, M. H., Kondos, G. T., D’Agostino, R. B., Perez, A., Provost, J.-C., & Haffner, S. M. (2006) · JAMA

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 674

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Circulation

Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular Health

Cited by 664

Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study

Fox, C. S., Coady, S., Sorlie, P. D., D’Agostino, R. B., Pencina, M. J., Vasan, R. S., Meigs, J. B., Levy, D., & Savage, P. J. (2007) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsHealthcare Systems and Public Health

Cited by 656

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women

Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 608

Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries

Islam, N., Sharp, S. J., Chowell, G., Shabnam, S., Kawachi, I., Lacey, B., Massaro, J. M., D’Agostino, R. B., & White, M. (2020) · BMJ

COVID-19 epidemiological studiesCOVID-19 Prevention and Impact

Cited by 601

Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk

Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 509

Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study

Jeerakathil, T., Wolf, P. A., Beiser, A., Massaro, J., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2004) · Stroke

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 479

Sudden coronary death in women

Kannel, W. B., Wilson, P. W. F., D’Agostino, R. B., & Cobb, J. (1998) · American Heart Journal

Cardiac electrophysiology and arrhythmiasCardiac Health and Mental Health

Cited by 417

Obesity, diabetes and cognitive deficit: The Framingham Heart Study

Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D’Agostino, R. B. (2005) · Neurobiology of Aging

Dementia and Cognitive Impairment ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 395

Challenges in the design and interpretation of Noninferiority trials

Mauri, L., & D’Agostino, R. B. (2017) · New England Journal of Medicine

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 395